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Langerhans cell histiocytosis (LCH) is a rare disorder characterized by high proliferation of Langerhans dendritic 
cells. LCH is a solitary or multifocal disease that primarily involves bone tissue and often affects children and 
young men. A 29 years-old Caucasian man was referred to the Oral Surgery Unit of George Eastman Hospital - 
Umberto I teaching hospital, with third degree mobility of teeth belonging to second, third and fourth quadrant. 
Panoramic radiograph showed multiple radiolucent areas with well demarcated borders on the right and left site 
of the mandible and on the left site of the maxilla. Extractions of compromised teeth and biopsy of the osteolytic 
tissue were performed. The final diagnosis of multisystem Langerhans cell histiocytosis of the soft and hard tissues 
of the oral cavity was made. The patient was sent to the Hematology department of Umberto I Teaching Hospital 
of “Sapienza” – University of Rome for the proper treatment. The present case of rare multisystem LCH involving 
oral hard and soft tissues shows the strong importance of better investigate, with appropriate additional exams, 
initial shifty symptoms that could lead to a misdiagnosis.




Langerhans cell histiocytosis (LCH) is a historically po-
orly understood hematologic disorder with a wide range 
of clinical presentations characterized by granulomatous 
lesions composed of clonal pathologic “histiocytes” 
(CD207+ cells). LCH may present with a wide spectrum 
of symptoms, ranging from self-resolving single-organ 
lesions to disseminated multi-organ disease, which is 
associated with 10% to 20% mortality and it affects 4 
to 8 children per million and 1 to 2 adults per million 
each year (1,2). Incisional biopsy is fundamental becau-
se of the cellular heterogeneity of the lesions and the 
possible presence of physiologic resident or migrating 
langerin-positive (CD207+) dendritic cells. The typical 
architecture of tissues affected by the disease shows a 
mixture of pathologic dendritic cells and recruited infla-
mmatory cells, including lymphocytes, eosinophils, and 
macrophages. Pathologic histiocytes have abundant pink 
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cytoplasm, a deep groove in the nucleus that gives them 
a coffee bean–like appearance, and positive immunohis-
tochemical staining for CD1a, S100 and CD207 (3).
Clinical lesions involve bone, skin, liver, spleen, lympha-
tic system, bone narrow, lung and oral cavity. Bone and 
skin are the most commonly involved organs. Bone le-
sions appear in 75% of patients and skin lesions in 34% 
(1,2).
Skeletal lesions of LCH often affect skull, long bones, 
pelvis, ribs, vertebra, facial bones and jaws, particularly 
the posterior regions of the mandible (4). Oral mucosa 
involvement is uncommon and it is characterized by gin-
gival hypertrophy and ulcers of the buccal mucosa, hard 
and soft palate and tongue (5).
The clinical course of the adult onset LCH seems to be 
unpredictable, but in many cases, it regresses sponta-
neously or after adequate therapy (6).
This report describes a rare case of multisystem Langer-
hans cell histiocytosis with oral cavity soft and hard tissues 
involvement and shows the importance of the integration 
of radiograph examinations, histological and immunohisto-
chemistry analysis for reaching the correct diagnosis. 
Case Report
A 29 years-old Caucasian man was referred to the Oral 
Surgery Unit of George Eastman Hospital - Umberto I 
teaching hospital, with increased mobility of teeth be-
longing to second, third and fourth quadrant. 
The patient had no significant systemic disease, he did 
not take drugs and his past medical history did not reveal 
any significant events. 
His private dentist had previously extracted the second 
upper right premolar affected by destructive caries, the 
second upper left molar, the second and third lower left 
molars and the second lower right molar affected by se-
vere periodontal disease. 
Intraoral examination revealed poor oral hygiene, diffu-
se gingival inflammation and impairment of the perio-
dontal support with third degree mobility of teeth: 2.6, 
2.8, 3.6, 4.6 and 4.7.
Panoramic radiograph showed multiple radiolucent 
areas with well demarcated borders on the right and left 
mandible and on the left maxilla. The severe alveolar 
bone resorption of the jaws was located in the region ad-
jacent to teeth from 2.4 to 2.8, from 3.3 to 3.6 and from 
4.5 to 4.7 (Fig. 1).
The presence of osteolytic lesions was confirmed by a 
subsequent 3D examination with CT scan (Fig. 2).
Tooth extractions of 2.8-4.6-4.8 were performed and an 
incisional biopsy of the osteolytic tissue was sent for 
histopathological and immunohistochemical examina-
tions to the U.O.C. Pathological Anatomy of S.Spirito 
Hospital, ASL Roma 1, Rome, Italy.
Histological and immunohistochemistry analysis revea-
led a large cellular infiltrate attacking the epithelium sur-
Fig. 1: Pre-operative orhopantomography showing well-demarcated 
radiolucent areas that involve all the dental elements belonging to the 
third, fourth and sixth sextant. 
Fig. 2: CT scan examination that confirms the presence of oste-
olytic lesions.
face with wide ulcerations.  The inflammatory infiltrate 
mainly composed by mononuclear histiocytic cells was 
positive to S100 protein and to CD1a, CD207, CD68, 
CD68 (Kp-1) antigen markers (Fig. 3).
According to these findings the final diagnosis of mul-
tisystem Langerhans cell histiocytosis of the oral cavity 
was made. 
The patient was sent to the Hematology department of 
Umberto I Teaching Hospital of “Sapienza” – University 
of Rome to evaluate the extent of disease and the appro-
priate treatment.
Complete blood laboratory tests were all within normal 
limits and infectious disease tests do not show abnor-
malities.
Chest X-ray confirmed the presence of osteolytic lesions 
on the right IV,V,VI ribs and on the left III, IV, VII, VIII 
ribs. 
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Fig. 3: Histologic appearance (Hemat/Eos). Different magnifica-
tions. Large cellular infiltrate composed by mononuclear histiocytic 
cells attacking the epithelium surface with wide ulcerations.
Radiographic examination of both femurs showed oval 
radiolucent lesion on the upper third of the right femoral 
diaphysis with perilesional sclerosis also at the level of 
the right ischio-pubic area; osteolytic lesions were de-
tected on the left iliac crest and on the upper third of the 
left femoral diaphysis, surrounded by a thick margin of 
reactive bone.
Total body CT scan with technetium-99m methylene 
diphosphonate (MDP- Tc-99m) revealed regions of in-
creased uptake in the lateral arch of the left VII rib, in the 
posterior level of the ipsilateral VIII rib, in the posterior 
arch of the right V rib and in both femoral diaphysis.
A MRI of head highlighted mucositic cysts of the right 
and left sinus and lack of homogeneity of the cranial 
bone.
Ultrasonographic examination of the abdomen excluded 
involvement of “Risk Organs” (Hematopoietic system, 
spleen, and/or liver) (7).
The presence of multifocal bone lesions and the involve-
ment of the oral mucosa showed the involvement of va-
rious organ/system. The final diagnosis of multisystem 
LCH without involvement of “Risk Organs” was made.
Therapy according to the GIMEMA (Gruppo Italiano 
Malattie EMatologiche dell’Adulto) LCH 2001 was star-
ted. Vinblastine at a dosage of 6 mg/sqm/weekly (10 mg 
full dose) for a total of six doses combined with Predni-
sone (PDN) 40 mg/sqm/daily for three weeks then tape-
red over six weeks was given as induction treatment.
Combined to systemic therapy, an individual oral hygie-
ne program stressing the importance of the correct use 
of toothbrush, dental floss, inter-dental brushes, and of 
0.2% chlorhexidine mouth rinsing to obtain the best pos-
sible control of plaque was suggested to the patient.
A causal periodontal treatment with supragingival and 
subgingival scaling was performed in order to eliminate 
any source of inflammation. 
Subsequently a surgical curettage of the lesions was per-
formed. 
During the I phase of treatment the patient underwent 
supra and subgingival scaling periodically, every two 
weeks for the first two months and every forty-five days 
for the following six months.
After six months period of follow-up, a panoramic ra-
diography showed that there was no sign of aggravation 
of oral lesions.
The patient is currently under treatment and radiographi-
cal examinations are scheduled. 
Discussion
A brief literature review conducted by the authors re-
veals that Langerhans cell histiocytosis is a rare disorder 
characterized by proliferation of Langerhans dendritic 
cells.
The pathogenesis of LCH can include oral lesions as 
well as bone, mucosal and periodontal lesions.
Bone lesions are the most common; they are often lo-
calized in an area between the cranium, the maxilla and 
the mandible. Such lesions can be solitary intra-bony 
lesion, multiple alveolar lesions, scooped-out alveolar 
lesions, alveolar lesions with bone sclerosis or alveolar 
lesions with bone neoformation. The posterior region of 
the mandible is considered the most frequently invol-
ved region. Mucosal lesions are usually localized in the 
buccal mucosa and at the back of the vestibule. They 
present themselves as ulcerated, ovoid or round lesions 
with erythematous, inflamed borders, painful at the pal-
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pation. Such lesions may be associated with lymphade-
nopathies or with cutaneous lesions. Periodontal lesions 
like gingival inflammation, ulceration, destruction of 
the keratinized gingiva, gingival recession, periodontal 
pockets and bleeding of the oral soft tissues appear as a 
consequence of the alveolar bone loss. Teeth surrounded 
by radiolucent defect related to LCH begin to move as 
“floating teeth” with consequent dental displacement, 
dental pain and premature loss (8).
The present case of rare multisystem LCH involves oral 
hard and soft tissues.
The patient shows mucosal erythematous ulcerated le-
sion, third degree teeth mobility and multifocal lesions 
involving the mandibular bone and the upper left region 
of the maxilla. Those lesions were the first manifestation 
of the LCH disease. 
It is important to focus that a third degree teeth mobility 
in a young patient is a wake up call for the dentists.
A good integration of medical and dental history, clini-
cal examination, radiograph exams, histological and im-
munohistochemistry analysis is mandatory to reach the 
correct diagnosis (9).
Histological analysis showed the presence of Langer-
hans cells and a variable amount of eosinophils, neu-
trophils, mononuclear and polynuclear histiocytes and 
lymphocytes. Langerhans cells are oval or rounded in 
shape, pale, and with a predominantly eosinophilic cyto-
plasm. Immunohistochemistry analysis revealed that 
Langerhans cells were positive to S-100 protein, ATP-
ase, alpha-D-mannosidase, and antigens CD1a and lan-
gerin (4).
The differential diagnosis of multifocal bone lesions of 
the oral cavity must include odontogenic cysts and tu-
mors, primary bone tumors, osteomyelitis, metastases, 
multiple myeloma, giant cell granuloma and lymphoma. 
Only the correct integration of information regarding 
the medical history, the age, the radiographic exams, 
the biopsy with histological and immunohistochemistry 
analysis and blood exams lead the clinicians to the pro-
per diagnosis (9).
The treatment of LCH actually is not clear and it de-
pends on the extent and the severity of the disease.
Single system LCH (SS-LCH) is characterized by the 
involvement of one organ/system with uni- or multifocal 
lesions. Such organs/systems can be: bone (unifocal - 
single bone - or multifocal - more than one bone -); skin; 
lymph node; hypothalamic-pituitary or central nervous 
system; lungs (known as primary pulmonary LCH); 
other (e.g. thyroid or gut). Multisystem LCH (MS-LCH) 
is characterized by two or more organs/systems involved 
with or without the involvement of “Risk Organs”.
In SS-LCH the treatment includes surgical curettage, 
topical injection of steroid, low dose of radiotherapy or 
observation of spontaneous regression (6).
In MS-LCH the treatment is characterized by systemic 
steroidal therapy, immunosuppressant agents, immune 
modulators or cytostatic drugs (10).
In this case of MS-LCH a systemic therapy with chemo-
therapy drug vinblastine with oral corticosteroids was 
prescribed and regular checks to monitor the disease are 
scheduled.
According to the report of the International Registry of 
the Histiocyte Society on adult LCH (IRHSA) which 
studied the clinical characteristics of 274 cases from 13 
nations, the probability of survival at 5 years postdiag-
nosis was 92.3% overall, 100% for patients with single-
system disease, 87.8% for isolated pulmonary disease, 
and 91.7% for multisystem disease. This demonstrates 
that the number of organs involved is a key factor affec-
ting the prognosis of LCH (11).
Reactivations of LCH in adults occur in about 25-38% 
of the patients especially in those with multisystem di-
sease (12).
In this case the absence of oral manifestations except 
teeth mobility showed the importance to better investi-
gate unusual findings such as third degree teeth mobi-
lity in a young patient with no history of periodontitis 
performing radiograph examinations and histological 
and immunohistochemistry analysis. Only the correct 
integration of the clinical, radiographic, histological 
and immunohistochemical data can allow the clinician 
to reach the final diagnosis and, if necessary, to set up a 
multidisciplinary treatment plan.
Oral lesions may be the earliest manifestation of the Lan-
gerhans cell histiocytosis and in many cases the mouth 
may be the only site involved. This finding highlights 
the importance of dentists to make a correct early LCH 
diagnosis that is of primary importance to improve the 
patient’s prognosis and quality of life.
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